These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 3917598)
1. Incomplete and delayed bioavailability of sublingual nitroglycerin. Noonan PK; Benet LZ Am J Cardiol; 1985 Jan; 55(1):184-7. PubMed ID: 3917598 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets. Kwon HR; Green P; Curry SH Biopharm Drug Dispos; 1992 Mar; 13(2):141-52. PubMed ID: 1550909 [TBL] [Abstract][Full Text] [Related]
3. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet. Jensen KM; Mikkelsen S Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449 [TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutical evaluation of methylcellulose as an excipient for nitroglycerin tablets. Shibuya F; Kuramoto K; Koizumi H; Uehara N; Nakagawa F; Tamura Z; Murayama M; Kawakubo K; Kawahara T; Ohshiro M J Pharmacobiodyn; 1985 May; 8(5):352-6. PubMed ID: 3930694 [TBL] [Abstract][Full Text] [Related]
5. Relative bioavailability of two spray formulations of nitroglycerin. Sanders SW; Michaelis K; Maurette JM; Jaeger H J Pharm Sci; 1986 Mar; 75(3):244-6. PubMed ID: 3084758 [TBL] [Abstract][Full Text] [Related]
6. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS). Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)]. Maier-Lenz H; Ringwelski L; Windorfer A Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443 [TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites. Jensen KM; Dahl JB Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539 [TBL] [Abstract][Full Text] [Related]
9. Variable glyceryl dinitrate formation as a function of route of nitroglycerin administration. Noonan PK; Benet LZ Clin Pharmacol Ther; 1987 Sep; 42(3):273-7. PubMed ID: 3113806 [TBL] [Abstract][Full Text] [Related]
11. Relation of time course of plasma nitroglycerin levels to echocardiographic, arterial pressure and heart rate changes after sublingual administration of nitroglycerin. Wei JY; Reid PR Am J Cardiol; 1981 Oct; 48(4):778-82. PubMed ID: 6792895 [TBL] [Abstract][Full Text] [Related]
12. Relative bioavailability of a new transdermal nitroglycerin delivery system. Noonan PK; Gonzalez MA; Ruggirello D; Tomlinson J; Babcock-Atkinson E; Ray M; Golub A; Cohen A J Pharm Sci; 1986 Jul; 75(7):688-91. PubMed ID: 3093667 [TBL] [Abstract][Full Text] [Related]
14. New transdermal and transmucosal nitroglycerin delivery systems in patients with ischaemic heart disease. Metelitsa VI; Martsevich SYu ; Piotrovskii VK; Ryabokon OS; Blagodatskikh SV Eur J Clin Pharmacol; 1987; 32(1):5-10. PubMed ID: 3108009 [TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets. Marmor A Am J Cardiol; 1990 Jun; 65(21):43J-45J. PubMed ID: 2112337 [TBL] [Abstract][Full Text] [Related]